期刊文献+

溃疡性结肠炎(UC)肠黏膜中IL-2、IL-4、IL-17和IL-10的表达特点及其与疾病活动度的关系 被引量:52

The expressions of IL-2,IL-4,IL-17 and IL-10 in ulcerative colitis(UC) mucosa and its relation with disease activity
下载PDF
导出
摘要 目的探讨溃疡性结肠炎(ulcerative colitis,UC)患者肠黏膜中的细胞因子IL-2、IL-4、IL-17和IL-10的表达特点,并分析其与疾病活动度的关系。方法收集UC患者36例,采用Sutherland疾病活动指数评估UC的炎症活动度。行结肠镜检查时对UC患者的病灶部位及病灶周围正常肠黏膜组织进行活检,以半定量PCR法检测肠黏膜组织中的细胞因子IL-2、IL-4、IL-17和IL-10的表达水平。从中选取10例以免疫组化法检测肠黏膜组织中上述各细胞因子的表达,同时检测该10例UC患者外周血的血沉(erythrocyte sedimentationrate,ESR)及C反应蛋白(c-reactive protein,CRP)值。结果 IL-2在UC患者肠黏膜病灶部位中的表达水平明显高于周围正常黏膜。在UC患者不同活动度组间,IL-2的蛋白表达水平无显著差异,但轻度组的IL-2mRNA表达水平高于中、重度组。IL-4在病灶部位中的表达水平明显高于正常黏膜,其中重度UC患者中的IL-4表达水平明显高于轻、中度UC患者。IL-17在病灶部位中的表达水平高于正常黏膜,其中重度UC患者中的IL-17表达水平明显高于轻、中度UC患者。IL-10在病灶部位中的蛋白及mRNA表达水平均高于正常黏膜,但前者差异无统计学意义,其中轻度UC患者中的IL-10表达水平明显高于中、重度UC患者。UC患者肠黏膜中上述细胞因子的表达水平与ESR、CRP值均无明显相关性。结论 IL-2、IL-4、IL-17及IL-10通过发挥不同的促炎或抑炎作用可能参与介导了UC发病,其mRNA表达水平与UC的炎症活动程度存在一定相关性,其中IL-4、IL-17及IL-10的蛋白表达水平亦与UC的炎症活动程度存在一定相关性,可用来评估UC的炎症程度。 ] Objective To investigate the expression of cytokines including IL-2,IL-4,IL-17 and IL-10 in the mucosa of patients with ulcerative colitis (UC) ,in order to determine the correlation between the expression levels of these cytokines and disease activity. Methods Thirty-six cases of UC were enrolled in this study. The disease activity was scored by Sutherland DAI in UC patients. Endoscopic mucosa biopsy was performed when UC patients took colonoscopy examination. The expression levels of cytokines including IL-2, IL-4, IL-17 and IL-10 in the intestinal mucosa were assessed by semiquantitative PCR. In 10 cases, these cytokines were measured by immunohisochemistry, and peripheral blood erythrocyte sedimentation rate (ESR) and c-reactive protein (CRP) were measured simultaneously. Results The expression level of IL-2 was significantly higher in inflamed mueosa than in normal mueosa, but there was no evident difference in protein expression of IL-2 among subgroups of UC patients classified by disease activity. However, the mRNA expression of IL-2 was higher in mild group than in moderate and severe. The expression level of IL-4 was higher in inflamed mucosa than in normal mucosa. Among subgroups of UC patients, the expression level of IL-4 was higher in severe than in mild and moderate. The expression level of IL-17 was higher in inflamed mucosa than in normal mucosa. Among subgroups of UC patients, the expression level of IL-17 was higher in severe than in mild and moderate. The protein and mRNA expression levels of IL-10 were higher in inflamed mucosa than in normal mucosa,but no statistical significance in the former. Among subgroups of UC patients, the expression level of IL-10 was higher in mild than in moderate and severe. No correlation was seen between the expression levels of those cytokines and ESR or CRP level. Conclusions Cytokines like IL-2.IL-4.IL-17 and IL-10 may be involved in the pathogenesis of UC through pro-or anti-inflammation effect. The mRNA expression levels of these 4 cytokines and protein expression levels of IL-4.IL-17 and IL-10 are correlated with disease activity of UC to some extent,and can be used to evaluate the activity of UC.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2012年第5期454-459,488,共7页 Fudan University Journal of Medical Sciences
基金 上海市科委基金项目(09JC1402900)~~
关键词 IL-2 IL-4 IL-17 IL-10 溃疡性结肠炎(UC) IL-2 IL-4 IL-17 IL-10 ulcerative colitis (UC)
  • 相关文献

参考文献11

  • 1Macdonald TT, Monteleone G, Pender SL. Recent developments in the immunology of inflammatory bowel disease[J]. Scan J Immunol,2000,51(1) : 2 - 9.
  • 2Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past,present and future: lessons from animal models[J]. J Gastroenterol,2008,43(1) : 1 - 17.
  • 3欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495. 被引量:751
  • 4Alex P,Zachos NC, Nguyen T. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis[J]. Inflamm Bowel Dis, 2009,15 (3) :341 - 352.
  • 5Matsuoka K, Inoue N, Sato T. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Thl mediated immunopathology in Crohn's disease[J].Gut,2004,53(9):1303 - 1308.
  • 6Heller F,Florian P,Bo]arski C,et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution [J]. Gastroenterology,2005,129(2) :550 - 564,.
  • 7Pene J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Thl7 lymphocytes[J]. J Immunol, 2008,180 (11 ) : 7423 - 7430.
  • 8Kinugasa T, AndohSakaguchi T, Gu X, et al. Claudins regulate the intestinal barrier in response to immune mediators[J]. Gastroenterology, 2000, 118 ( 6 ) :1001 - 1011.
  • 9Ogawa A, Andoh A, Araki Y, et al. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice[J]. Clin Immunol, 2004,110(1) : 55 - 62.
  • 10Izeue A, Hue S, Buonocore S, et al. Interleukin-23 restrains regulatory T cell activity to drive T cell- dependent colitis [J].Immunity, 2008, 28 (4) : 559 - 570.

二级参考文献18

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3Ouyang Q,Tandon R,Goh KL,et al.The emergence of inflammatory bowel disease in the Asian Pacific region.Curr Opin Gastroenterol,2005,21 (4):408-413.
  • 4Satsangi J,Silverberg MS,Vermeire S,et al.The Montreal classification of inflammatory bowel disease:controversies,consensus,and implications.Gut,2006,55(6):749-753.
  • 5Kornbluth A,Sachar DB; Practice Parameters Committee of the American College of Gastroenterology.Ulcerative colitis practice guidelines in adults (update):American College of Gastroenterology,Practice Parameters Committee.Am J Gastroenterol,2004,99 (7):1371-1385.
  • 6Hanauer SB,Sandborn W; Practice Parameters Committee of the American College of Gastroenterology.Management of Crohn's disease in adults.Am J Gastroenterol,2001,96 (3):635-643.
  • 7Stange EF,Travis SP,Vermeire S,et al.European Crohn's and Colitis Organisation.European evidence based consensus on the diagnosis and management of Crohn's disease:definitions and diagnosis.Gut,2006,55Suppl 1:i1-i15.
  • 8Carter MJ,Lobo AJ,Travis SP; IBD Section,British Society of Gastroenterology.Guidelines for the management of inflammatory bowel disease in adults.Gut,2004,53 Suppl 5:V1-V16.
  • 9Shivananda S,Hordijk ML,Ten Kate FJ,et al.Differential diagnosis of inflammatory bowel disease.A comparison of various diagnostic classifications.Scand J Gastroenterol,1991,26 (2):167-173.
  • 10樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.

共引文献750

同被引文献564

引证文献52

二级引证文献369

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部